PRESS RELEASE published on 05/21/2025 at 08:00, 1 year 5 months ago Informations privilégiées / Autres communiqués TME Pharma, société de biotechnologie spécialisée en thérapies contre le cancer, prolonge sa visibilité financière jusqu'en mai 2026 via une émission d'obligations aux investisseurs professionnels Investisseurs Obligations Cancer Visibilité Financière TME Pharma
BRIEF published on 04/10/2025 at 19:05, 1 year 7 months ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
BRIEF published on 04/10/2025 at 19:05, 1 year 7 months ago TME Pharma renforce son contrat de liquidité avec Invest Securities Contrat De Liquidité INVEST SECURITIES Marchés Financiers Oncologie TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year 7 months ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year 7 months ago Informations privilégiées / Autres communiqués TME Pharma augmente les ressources allouées au contrat de liquidité confié à Invest Securities pour renforcer la trésorerie. Détails des ressources disponibles après l'augmentation Contrat De Liquidité INVEST SECURITIES Trésorerie Ressources TME Pharma
BRIEF published on 02/17/2025 at 08:05, 1 year 8 months ago TME Pharma présente sa feuille de route stratégique et ses initiatives pour 2025 Biotechnologie Partenariats Stratégiques Thérapie Contre Le Cancer Découverte De Médicaments NOX-A12
BRIEF published on 02/17/2025 at 08:05, 1 year 8 months ago TME Pharma Outlines 2025 Strategic Roadmap and Initiatives Strategic Partnerships Biotechnology Drug Discovery Cancer Therapy NOX-A12
PRESS RELEASE published on 02/17/2025 at 08:00, 1 year 8 months ago Inside Information / Other news releases TME Pharma CEO Aram Mangasarian outlines key initiatives and milestones for 2025, including strategic partnerships, NOX-A12 clinical development, AI-driven drug discovery, and financial updates Strategic Partnerships Clinical Development CEO Message TME Pharma 2025 Initiatives
BRIEF published on 01/29/2025 at 08:05, 1 year 9 months ago TME Pharma et aimed analytics : Partenariat innovant pour la découverte de médicaments par l'IA Biotechnologie Partenariat Intelligence Artificielle Cancer Médicaments
BRIEF published on 01/29/2025 at 08:05, 1 year 9 months ago TME Pharma and aimed analytics: Innovative partnership for drug discovery through AI Biotechnology Artificial Intelligence Partnership Cancer Drugs
Published on 11/14/2026 at 12:56, 11 hours 44 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 23 hours 10 minutes ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 1 hour ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 2 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 5 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 5 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 13 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 13 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day 16 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 1 hour ago Belgrano continues the implementation of its public share buyback offer (OPRA)
